East and Central Asia

Cerveau Technologies Inc. Signs Research Agreement with Eisai Inc., for Novel Tau Imaging Agent

BOSTON–(BUSINESS WIRE)–Cerveau Technologies, Inc. today announced a research collaboration agreement with Eisai Inc., which will enable Eisai to use Cerveau’s

Posted in Asia, news, North America | Tagged , | Leave a comment

Eisai, Biogen kick-off phase 3 testing early Alzheimer’s disease antibody, amid dropping aducanunab trial. Eisai’s US company presents AD pipeline

Eisai Co said Friday thata global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid beta protofibril antibody, in patients with early Alzheimer’s disease has been initiated.

Posted in Approval, Asia, Europe, North America, Regions | Tagged , , | Leave a comment

LegoChem Biosciences and Takeda Enter into a Multi-Target Research Collaboration and License Agreement for the Development of Antibody-Drug Conjugates in Immuno-Oncology

– Takeda obtains rights to LCB’s ADC platfo–LegoChem Biosciences, Inc. (“LCB”) (KOSDAQ:141080) announced today that it has entered a research

Posted in Asia, news | Tagged , , | Leave a comment

Aerie Pharmaceuticals Initiates Netarsudil Ophthalmic Solution Phase 2 Clinical Trial in Japan Designed to Support Requirements for Future Regulatory Filing

DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class

Posted in Asia, news | Tagged | Leave a comment

Alvogen’s Taiwan company – Lotus – exchange stake with Fuji Pharma

@alvogenpr subsidiary in Taiwan, Lotus Pharmaceuticals today announced capital and business collaboration agreements with Fuji Pharma in Japan, as Fuji has acquired a 2.0% stake in Lotus for approximately US$20 million (or NT$ 617 million, JPY 2.2 billion). Lotus has also acquired 3.9% stake in Fuji for an equal sum.

Posted in Approval, Asia, Europe, news | Tagged , , | Leave a comment

Center for Gene and Cell Therapy Co-founded by Miltenyi and ATLATL in Shanghai

SHANGHAI–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Shanghai?src=hash" target="_blank"gt;#Shanghailt;/agt;–To accelerate the development of cell and gene therapy, ATLATL Center and Miltenyi Biotec have cooperated to build ATLATL-MACS Center

Posted in Approval, Asia, news, Regions | Tagged | Leave a comment

Mundipharma China to sell Swiss Helsinn’s first cancer supportive care in China

Swiss Helsinn Group and Mundipharma China Pharmaceutical will now sell ALOXI IV in China, as it got approval from the

Posted in Approval, Asia, news | Tagged , , , , | Leave a comment

First Japanese company joins CARB-X partnership in the fight against drug resistant bacteria

CARB-X is partnering with Shionogi of Osaka, Japan, to support the development of a novel β-lactam antibiotic with potent activity

Posted in Asia, news, North America | Tagged , , | Leave a comment

Premaitha signs new partner to offer NIPT solution in East Asia

Premaitha Health has signed an agreement with a new laboratory partner to offer an NIPT screening solution in a new East Asian territory for Premaitha.  

Posted in Asia, Europe, news, Regions | Leave a comment

Basilea Pharmaceutica in license agreement with Chinese drugmaker

Basilea Pharmaceutica has entered into a license agreement with Shenzhen China Resources Gosun Pharmaceutical Co., Ltd. (CR Gosun) for Basilea’s antibiotic Zevtera (ceftobiprole) in China, Hong Kong and Macao (the Territory).

Posted in Asia, news, Regions | Tagged , , | Leave a comment